CGC (Canopy Growth Corp.) Long-Term Debt

Brandmark of Tweed (CGC)

The biomedical sector of Canopy Growth (CGC) operates amid diplomatic stability, making the stock's chart on the GURU.Markets platform a convenient monitoring tool. The business relies on expanding its range of extracts and beverages for global markets to mitigate legal threats. However, financial stability remains weak due to oversupply and capital burn, while the long-term liabilities indicator stands at 0.17.

CGC Canopy Growth Corp.: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Analytical breakdowns for Canopy Growth

- price and consensus price forecast:
Stock Quotes canopygrowth.com|CGC - Price Target Chart
- market capitalization data:
Market Value Canopy Growth|CGC - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Canopy Growth|CGC - Book Capitalization|Market Capitalization to Net Assets canopygrowth.com|CGC - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Canopy Growth|CGC - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Canopy Growth Corp.|CGC - Company Debts|Debt to Book Value Canopy Growth|CGC - Company Long-Term Debts|Company Current Liabilities Canopy Growth
Fundamental company valuation:CGC (canopygrowth.com)
Manufactured products of Canopy Growth Corp.

To objectively assess the issuer's credit profile, a manager requires an analysis of long-term liabilities via market value. This indicator filters out short-term volatility, reflecting the real dynamics of borrowings through the lens of daily trading. By analyzing the company's long-term debt, an investor determines the balance between financial stability and expansion rates. For Canopy Growth (CGC), this trend is critical due to high cash burn and unstable operating profit amid cannabis overproduction.

Competitor analysis for Canopy Growth

indivior.com - Company Long-Term Liabilities|COLL (Collegium Pharmaceutical, Inc.) - Company Long-Term Debt|Cronos Group Inc (CRON) - Long-Term Debt|Company Long-Term Liabilities High Tide Corp HITI|Aurora Cannabis Inc. (ACB) - Company Long-Term Loans and Borrowings|Company Long-Term Debts Achieve Life Sciences ACHV|Long-Term Liabilities Skye Bioscience Inc.|Company Long-Term Debts ANEB|Company Long-Term Debts INCR (intercure.co)|Company Long-Term Debt Nutriband|Nasus Pharma Ltd. - Company Long-Term Loans and Borrowings|IGC: Company Long-Term Debt|MIRA - Company Long-Term Liabilities|FLGC (Flora Growth) - Company Long-Term Debts|IM Cannabis (IMCC) - Company Long-Term Liabilities|ADIL (Adial Pharmaceuticals Inc.) - Company Long-Term Debts|Company Long-Term Debts ARTL|Company Long-Term Debt Ensysce Biosciences ENSC|Company Long-Term Indebtedness TTNP (titanpharm.com)|GNLN: Company Long-Term Debt|InMed Pharmaceuticals Inc - Long-Term Debt|Company Long-Term Debt Akanda Corporation|Enveric Corp (ENVB) - Long-Term Liabilities|Company Long-Term Liabilities BGXX|Long-Term Debt hempaccoinc.com